Eurolink United Ltd exits London health tech firm Metadvice Ltd

Eurolink United Ltd has exited the cap table of Metadvice Ltd, according to the company's latest confirmation statement. The entity previously held 41,250 Ordinary shares in the business. This disposal was the only shareholder change recorded during the reporting period, which ended on 4 April 2026.

Metadvice Ltd is a London-based health technology company founded in 2019. The business develops an AI-driven software platform designed to provide clinical decision intelligence to healthcare professionals and systems. Its technology analyzes clinical guidelines, patient data, and historical clinical decisions to offer personalized treatment recommendations for patients living with complex and chronic conditions.

The filing, submitted on 21 June 2026, confirms that Eurolink United Ltd held 41,250 shares at the start of the period before the transfer of its entire stake. No new investors joined the cap table during this timeframe, and no existing shareholders increased their positions. Metadvice Ltd continues its operations from its London headquarters, focusing on the deployment of its clinical intelligence tools within healthcare environments. The removal of Eurolink United Ltd leaves the remaining shareholder structure as it was at the beginning of the period, minus this specific holding.